NCT07075783View on ClinicalTrials.gov

The Efficacy and Safety of Magnesium Sulphate Adjuvant in Scalp Block With Ropivacaine for Supratentorial Craniotomy: a Prospective, Randomized Controlled Trial

PHASE4CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

October 3, 2024

Primary Completion Date

April 15, 2025

Study Completion Date

May 20, 2025

Conditions
Efficacy and Safety of MgSO4 as Adjuvant to Scalp Block
Interventions
DRUG

MgSO4 plus Ropivacaine

1ml 50% MgSO4 added to 0.375% Plain Ropivacaine plus 5 mcg/ml adrenaline for scalp block

OTHER

Plain Ropivacaine

0.375% Plain Ropivacaine plus 5 mcg/ml adrenaline and 1 ml of 0.9% NaCl

Trial Locations (1)

16150

Hospital Pakar Universiti Sains Malaysia, Kubang Kerian

All Listed Sponsors
lead

Hospital Universiti Sains Malaysia

OTHER

NCT07075783 - The Efficacy and Safety of Magnesium Sulphate Adjuvant in Scalp Block With Ropivacaine for Supratentorial Craniotomy: a Prospective, Randomized Controlled Trial | Biotech Hunter | Biotech Hunter